Literature DB >> 26635930

Catheter-based intervention for symptomatic patient with severe mitral regurgitation and very poor left ventricular systolic function - Safe but no room for complacency.

Poay Huan Loh1, Christos V Bourantas1, Pak Hei Chan1, Nikolaj Ihlemann1, Fin Gustafsson1, Andrew L Clark1, Susanna Price1, Carlo Di Mario1, Neil Moat1, Farqad Alamgir1, Rodrigo Estevez-Loureiro1, Lars Søndergaard1, Olaf Franzen1.   

Abstract

Many patients with left ventricular systolic dysfunction have concomitant mitral regurgitation (MR). Their symptoms and prognosis worsen with increasing severity of MR. Percutaneous MitraClip(®) can be used safely to reduce the severity of MR even in patients with advanced heart failure and is associated with improved symptoms, quality of life and exercise tolerance. However, a few patients with very poor left ventricular systolic function may experience significant haemodynamic disturbance in the peri-procedural period. We present three such patients, highlighting some of the potential problems encountered and discuss their possible pathophysiological mechanisms and safety measures.

Entities:  

Keywords:  Chronic heart failure; Left ventricular systolic dysfunction; MitraClip; Mitral regurgitation; Mitral valve; Percutaneous

Year:  2015        PMID: 26635930      PMCID: PMC4660477          DOI: 10.4330/wjc.v7.i11.817

Source DB:  PubMed          Journal:  World J Cardiol


  20 in total

1.  Experimental mitral regurgitation: effects on left ventricular function before and after elimination of chronic regurgitation in the dog.

Authors:  J S Rankin; L M Nicholas; N T Kouchoukos
Journal:  J Thorac Cardiovasc Surg       Date:  1975-09       Impact factor: 5.209

Review 2.  Mitral valve surgery in advanced heart failure.

Authors:  Thomas G Di Salvo; Michael A Acker; G William Dec; John G Byrne
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

3.  Exhaustion of the Frank-Starling mechanism in conscious dogs with heart failure induced by chronic coronary microembolization.

Authors:  Robert M Gill; Bonita D Jones; Angela K Corbly; Dan G Ohad; Gerald D Smith; George E Sandusky; Michael E Christe; Jie Wang; Weiqun Shen
Journal:  Life Sci       Date:  2006-04-19       Impact factor: 5.037

4.  Preserved Frank-Starling mechanism in human end stage heart failure.

Authors:  J Weil; T Eschenhagen; S Hirt; O Magnussen; C Mittmann; U Remmers; H Scholz
Journal:  Cardiovasc Res       Date:  1998-02       Impact factor: 10.787

5.  Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels.

Authors:  C Holubarsch; T Ruf; D J Goldstein; R C Ashton; W Nickl; B Pieske; K Pioch; J Lüdemann; S Wiesner; G Hasenfuss; H Posival; H Just; D Burkhoff
Journal:  Circulation       Date:  1996-08-15       Impact factor: 29.690

6.  Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction.

Authors:  Olaf Franzen; Stephan Baldus; Volker Rudolph; Sven Meyer; Malgorzata Knap; Dietmar Koschyk; Hendrik Treede; Achim Barmeyer; Joachim Schofer; Angelika Costard-Jäckle; Michael Schlüter; Hermann Reichenspurner; Thomas Meinertz
Journal:  Eur Heart J       Date:  2010-03-10       Impact factor: 29.983

7.  Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.

Authors:  Benjamin H Trichon; G Michael Felker; Linda K Shaw; Christopher H Cabell; Christopher M O'Connor
Journal:  Am J Cardiol       Date:  2003-03-01       Impact factor: 2.778

8.  Mitral valve replacement in dilated canine hearts with chronic mitral regurgitation. Importance of the mitral subvalvular apparatus.

Authors:  K L Yun; S C Rayhill; M A Niczyporuk; J I Fann; R E Zipkin; G C Derby; C E Handen; G T Daughters; N B Ingels; A F Bolger
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

9.  Experimental mitral regurgitation. Physiological effects of correction on left ventricular dynamics.

Authors:  J A Spratt; C O Olsen; G S Tyson; D D Glower; J W Davis; J S Rankin
Journal:  J Thorac Cardiovasc Surg       Date:  1983-10       Impact factor: 5.209

10.  Mitral valve replacement with and without chordal preservation in patients with chronic mitral regurgitation. Mechanisms for differences in postoperative ejection performance.

Authors:  J D Rozich; B A Carabello; B W Usher; J M Kratz; A E Bell; M R Zile
Journal:  Circulation       Date:  1992-12       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.